Nanatinostat
2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
Molecular Identity
Nanatinostat
2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide
PubChem CID: 49857317
2D Structure
Properties
C20H19FN6O2
Molecular Formula
394.40
Molecular Weight
g/mol
394.1554
Exact Mass
Da
1
XLogP
Drug-like (Lipinski: < 5)
103
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
592
Complexity
SMILES
Canonical SMILES
SMILES: C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NOIsomeric SMILES
SMILES: C1[C@@H]2[C@@H](C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NOSynonyms(20)
Nanatinostat1256448-47-1CHR-3996Hdac inhibitor CHR-3996Nanatinostat [USAN]VRX-3996YTL7A418KQUNII-YTL7A418KQCHEMBL1801250WHO 10911Nanatinostat (USAN)2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide2-((1alpha,5alpha,6alpha)-6-(((6-Fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-5-pyrimidinecarboxamide5-Pyrimidinecarboxamide, 2-((1alpha,5alpha,6alpha)-6-(((6-fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-NANATINOSTAT [INN]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Nanatinostat
Loading drug network...